Correlation between interleukin-17, interleukin-10 levels, mean platelet volume to platelet count ratio and APACHE II score in sepsis
DOI:
https://doi.org/10.2478/AMB-2025-0070Keywords:
sepsis, Interleukin-17, Interleukin-10, MPV/PC ratio, APACHE IIAbstract
Background: We used the Acute Physiology and Chronic Health Evaluation II (APACHE II) score to gauge the severity of sepsis. It was based on 12 physiological and laboratory measurements taken in the first 24 hours in the intensive care unit. The severity of sepsis correlates with the pro-inflammatory cytokine interleukin-17 (IL-17) and the anti-inflammatory cytokine interleukin-10. The mean platelet volume to platelet count (MPV/PC) ratio acts as a marker of inflammation in sepsis. Objective: The aim of this study is to prove the correlation between pro-inflammatory cytokines, anti-inflammatory cytokines, and markers of inflammation with APACHE II scores in septic patients. Materials and methods: A cross-sectional analytical observational study involving 35 sepsis patients was conducted. The enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of IL-17 and IL-10, and a hematology analyzer was used to determine the MPV/ PC ratio. The Pearson and Spearman correlation tests were used to analyze the data. Results: The mean level of IL-17 was 432.51 ± 355.92 pg/ml, IL-10 was 3.09 ± 1.04 pg/ml, and the MPV/PC ratio was 4.90 ± 2.89. The study found significant correlations between IL-17 levels, IL-10 levels, MPV/PC ratio, and the APACHE II score (r = 0.721, p = 0.00), (r = 0.430, p = 0.01), and (r = 0.408, p = 0.01), respectively. Conclusion: There was a strong positive correlation between IL-17 levels and APACHE II scores, and a moderate positive correlation between IL-10 levels, MPV/PC ratio, and APACHE II scores.
References
Singer M, Deutschman CS, Seymour C, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA – J Am Med Assoc. 2016; 315(8):801-10.
Chaudhry H, Zhou J, Zhong Y, et al. Role of cytokines as a double-edged sword in sepsis. 2015; 27(6):669–84.
Steen EH, Wang X, Balaji S, et al. The Role of the Anti-Inflammatory Cytokine Interleukin-10 in Tissue Fibrosis. Adv Wound Care. 2020; 9(4):184–98.
Vardon-Bounes F, Gratacap MP, Groyer S, et al. Kinetics of mean platelet volume predicts mortality in patients with septic shock. PLoS One. 2019;14(10):1–15.
Octora M, Mertaniasih NM, Semedi BP, Koendhori EB. Predictive Score Model of Clinical Outcomes Sepsis in Intensive Care Unit Tertier Referral Hospital of Eastern Indonesia. Open Access Maced J Med Sci. 2021 Dec. 5; 9(B):1710-6.
Hosseini M, Ramazani J. Evaluation of Acute Physiology and Chronic Health Evaluation II and sequential organ failure assessment scoring systems for prognostication of outcomes among Intensive Care Unit′s patients. Saudi J Anaesth. 2016;10(2):168–73.
Wu HP, Shih CC, Chu CM, et al. Effect of interleukin-17 on in vitro cytokine production in healthy controls and patients with severe sepsis. J Formos Med Assoc. 2015;114(12):1250–7.
Bosmann M, Sarma JV, Atefi G, et al. Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis. FASEB J. 2012; 26:1640–51.
Matsumoto H, Ogura H, Shimizu K, et al. The clinical importance of a cytokine network in the acute phase of sepsis. Sci Rep. 018;8(1):1–4.
Oh GH, Chung SP, Park YS, et al. Mean platelet volume to platelet count ratio as a promising predictor of early mortality in severe sepsis. 2017;47(3):323–30.
Lat TI, Mcgraw MK, White HD. Gender Differences in Critical Illness and Critical Care Research. Elsevier J. 2020;1:543-55.
Bösch F, Angele MK, Chaudry IH. Gender differences in trauma, shock and sepsis. Mil Med Res. 2018;5(1):1–10.
Nasir N, Jamil B, Siddiqui S, et al. Mortality in sepsis and its relationship with gender. Pakistan J Med Sci. 2015;31(5):12016.
Ahmed Ali M, Mikhael ES, Abdelkader A, et al. Interleukin-17 as a predictor of sepsis in polytrauma patients: a prospective cohort study. Eur J Trauma Emerg Surg. 2018 Aug;44(4):621-626.
Li L, Chen L, Lin F, et al. Study of the expression of inflammatory factors IL-4, IL-6, IL-10, and IL-17 in liver failure complicated by coagulation dysfunction and sepsis. J Infl amm Res. 2021;14:1447–53.
Rendon JL, Choudhry MA. Th17 cells: critical mediators of host responses to burn injury and sepsis. J Leukoc Biol. 2012;92(3):529–38.
Fan SL, Miller NS, Lee J, Remick DG. Diagnosing sepsis, The role of laboratory medicine. Clin Chim Acta. 2016; 460: 203-210.
Borisov B, Borisov D. Current aspects in the diagnosis and management of catheter-related sepsis, observed in patients undergoing hemodialysis with a tunneled catheter. Acta Medica Bulgarica. 2024; 10;51(3):70-3.
Ge Y, Huang M, Yao YM. Biology of Interleukin-17 and Its Pathophysiological Significance in Sepsis. Front Immunol. 2020;11(1):1–13.
Li Y, Wei C, Xu H, et al. The immunoregulation of Th17 in host against intracellular bacterial infection. Hindawi Mediat Inflamm. 2018;1:1–13.
Nakada T, Russell J, Boyd J, Walley K. IL-17A rs1974226 GG genotype is associated with increased susceptibility to Gram-positive infection and mortality of severe sepsis. Crit Care. 2012;16(15):1–9.
L’Heureux M, Kashiouris M, Fowler A, Fisher B. Association Between Il-10 and Mortality in Sepsis-Induced Ards. Chest. 2020; 158(4):621.
Angurana SK, Bansal A, Muralidharan J, et al. Cytokine Levels in Critically Ill Children With Severe Sepsis and Their Relation With the Severity of Illness and Mortality. J Intensive Care Med. 2021;36(5):576–83.
Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683-765.
Cherneva R, Cherneva Z. Infection, Inflammation and Immunity in Covid-19 Infection. Acta Medica Bulgarica. 2021;48(3): 77-82.
Fabri A, Kandara K, Coudereau R, et al. Characterization of Circulating IL-10-Producing Cells in Septic Shock Patients: A Proof of Concept Study. Front Immunol. 2021;11:1–10.
Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, et al. Sepsis: Multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev. 2013;93(3):1247-88.
Vélez-Páez JL, Armendáriz-Carvajal AC, Rueda-Barragán FE, et al. Utility of cytometric parameters and indices as predictors of mortality in patients with sepsis. Infectio. 2021;25(3):153–8.
Vincent JL. Emerging therapies for the treatment of sepsis. Curr Opin Anaesthesiol. 2015;28(4):411–6.
Kim CH, Kim SJ, Lee MJ, et al. An increase in mean platelet volume from baseline is associated with mortality in patients with severe sepsis or septic shock. PLoS One. 2015;10(3):113.
Lancé MD, Sloep M, Henskens YMC, Marcus MAE. Mean platelet volume as a diagnostic marker for cardiovascular disease: Drawbacks of preanalytical conditions and measuring techniques. Clin Appl Thromb. 2012;18(6):561–8.
Cho SY, Jeon Y, Kim W, et al. Mean platelet volume and mean platelet volume/platelet count ratio in infective endocarditis. Platelets. 2014;25(8):559–61.
Aydemir H, Piskin N, Akduman D, et al. Platelet and mean platelet volume kinetics in adult patients with sepsis. Platelets. 2015;26(4):331-5.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 G. Harviendo, P. Adhipireno, B. Rachmawati, E. Limijadi, D. Retnoningrum (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.
Journal Acta Medica Bulgarica 
